Sadhana Nitrochem approves EGM, preferential allotment, and capital hike
Sadhana Nitrochem's Board approved increasing authorized share capital to ₹305 Crore and a preferential allotment of 6.75 crore equity shares at ₹2.06 each, raising ₹13.90 Crore. An EGM is planned for May 22, 2026, for approvals. The appointment of Mrs. Sindhu Suneer Kotian as Independent Director was regularized.
The preferential allotment and capital increase are significant corporate actions that could impact the company's financial structure and future operations. The appointment of directors also contributes to governance.
The company is raising capital through preferential allotment, which will provide additional working capital, and is also making key appointments and increasing its authorized share capital, indicating positive corporate actions.
Sadhana Nitrochem Limited announced the outcomes of its Board Meeting held on April 29, 2026. The Board approved the regularization of Mrs. Sindhu Suneer Kotian as a Non-Executive Independent Director and the continuation of Mr. Asit Dhankumar Javeri as Executive Director upon reaching the age of 70+ years.
The company's authorized share capital will be increased from ₹300 Crore to ₹305 Crore, subject to member approval. Furthermore, the Board approved raising funds through a preferential allotment of 6,75,00,000 equity shares at ₹2.06 per share, aggregating to ₹13,90,50,000, to support working capital. The allotment is proposed to Mr. Niraj Bajaj and Ms. Poorvi Milan Chitalia.
An Extra-ordinary General Meeting (EGM) is scheduled for approximately May 22, 2026, to seek member approval for the capital increase and preferential allotment. The Board also approved availing NSDL's services for e-voting and video conferencing for the EGM and appointed a scrutinizer for the voting process.
What to do with a filing like this
Sadhana Nitrochem Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sadhana Nitrochem Limited. Read the original for the full detail.